News of Note—GlaxoSmithKline, Neon Therapeutics and more

Here's some other vaccine news of note for the week.

> GlaxoSmithKline touted positive efficacy data for Shingrix in adults who have undergone an autologous haematopoietic stem cell transplant. Release

> Cancer vaccine biotech Neon Therapeutics has raised $106 million. Globes article

> Gavi, the Vaccine Alliance, pledged $85 million to help bring typhoid vaccines to poor countries. Reuters article

> Researchers are testing a new therapeutic vaccine in pediatric patients with a tough-to-treat brain tumor called diffuse intrinsic pontine glioma. FierceBiotechResearch article